Viridian Therapeutics, Inc.\DE

VRDN · Nasdaq · SIC 2834: Pharmaceutical Preparations
269
SEC Filings

Business Summary

PART I Company Overview We are a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases. We target therapeutic areas in which current treatments leave room for improvements in efficacy, safety, and/or dosing convenience. We believe there is significant potential in these areas, for better medicines that address unmet needs, improve outcomes, and expand treatment options for patients. We aim to develop diff...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVRDNdiscussed_in_filing Cybersecurity
topic_mentionVRDNdiscussed_in_filing Trusted Computing
topic_mentionVRDNdiscussed_in_filing Blockchain & Crypto
topic_mentionVRDNdiscussed_in_filing Capital Expenditure
topic_mentionVRDNdiscussed_in_filing Supply Chain
topic_mentionVRDNdiscussed_in_filing Regulation
topic_mentionVRDNdiscussed_in_filing Healthcare & Bio
topic_mentionVRDNdiscussed_in_filing Sovereign & Government
topic_mentionVRDNdiscussed_in_filing Cybersecurity
topic_mentionVRDNdiscussed_in_filing Trusted Computing
topic_mentionVRDNdiscussed_in_filing Blockchain & Crypto
topic_mentionVRDNdiscussed_in_filing Capital Expenditure
topic_mentionVRDNdiscussed_in_filing Supply Chain
topic_mentionVRDNdiscussed_in_filing Regulation
topic_mentionVRDNdiscussed_in_filing Healthcare & Bio
topic_mentionVRDNdiscussed_in_filing Sovereign & Government
topic_mentionVRDNdiscussed_in_filing Cybersecurity
topic_mentionVRDNdiscussed_in_filing Trusted Computing
topic_mentionVRDNdiscussed_in_filing Blockchain & Crypto
topic_mentionVRDNdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001590750-26-000007EDGAR101K words
2025-03-032024-12-310001590750-25-000004EDGAR—
2024-02-272023-12-310001590750-24-000007EDGAR—
2023-03-092022-12-310001590750-23-000002EDGAR—
2022-03-112021-12-310001590750-22-000004EDGAR—
2021-03-262020-12-310001590750-21-000029EDGAR—
2020-03-132019-12-310001590750-20-000021EDGAR—
2019-03-142018-12-310001590750-19-000013EDGAR—
2018-03-152017-12-310001590750-18-000006EDGAR—
2017-03-242016-12-310001171843-17-001747EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001590750-25-000020EDGAR62K words
2025-08-062025-06-300001590750-25-000012EDGAR—
2025-05-062025-03-310001590750-25-000008EDGAR—
2024-11-122024-09-300001590750-24-000023EDGAR—
2024-08-082024-06-300001590750-24-000019EDGAR—
2024-05-082024-03-310001590750-24-000012EDGAR—
2023-11-132023-09-300001590750-23-000013EDGAR—
2023-08-082023-06-300001590750-23-000008EDGAR—
2023-05-102023-03-310001590750-23-000003EDGAR—
2022-11-142022-09-300001590750-22-000012EDGAR—
2022-08-152022-06-300001590750-22-000009EDGAR—
2022-05-132022-03-310001590750-22-000007EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130433EDGAR9K words
2026-02-260001193125-26-073391EDGAR—
2025-11-050001193125-25-265711EDGAR—
2025-10-230001193125-25-247410EDGAR—
2025-10-210001193125-25-245206EDGAR—
2025-10-200001193125-25-243039EDGAR—
2025-08-060001193125-25-173983EDGAR—
2025-07-300001193125-25-168614EDGAR—
2025-06-240001193125-25-145741EDGAR—
2025-05-200001193125-25-122821EDGAR—

269 total filings indexed. 237 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001590750
TickerVRDN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e8bdff5fcb7a852f47a79721ab5d942c9c931c16410f08450f4bbdfa9aebae0b
parent: 8c02c0e243a622b63b6019e0c128ae545a4eb5f57f1672cff571e22ccf0207d0
content hash: 6e81a1f7205cb3ab3b7c851045f9278e13f222ea175738c624c9e9f9dea9c0b8
signed: 2026-04-13T04:48:07.861Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf